United States FDA Guidance Document

Read the United States Food and Drug Administration's document that was developed as a special control to support the classification of Factor V Leiden (FVL) DNA mutation detection systems into class II (special controls).

Prothrombotic Disorders in Infants with Neonatal Cerebral Infarction

Link to a study that evaluates the occurrence of prothrombotic disorders in a well-characterized cohort of infants with neonatal stroke and to document any association of prothrombotic disorders with the type of infarct seen on magnetic resonance imaging (MRI) and clinical outcome.